Mark Mitchell is an associate in the firm’s global life sciences transactions team. He advises life sciences companies on strategic collaboration agreements, licensing arrangements and other commercial transactions that arise throughout a product’s life cycle. Mark has experience supporting clients with commercial and IP due diligence in connection with their M&A matters.